Compounded tirzepatide
Sold by Prime Doctor RX · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$339
| Medication · Month-to-month, billed every 4 weeks | $339 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Month-to-month, billed every 4 weeksAdvertised “Tirzepatide Injection Personalized GLP-1/GIP care with tirzepatide injection when clinically appropriate. $269 / mo* Month-to-month: $339 every 4 weeks 12 weeks upfront $927 · $309/mo 24 weeks upfront $1,734 · $289/mo 52 weeks upfront $3,497 · $269/mo” | Per month$339 | Charged today$339 |
| 12 weeks paid upfront “Tirzepatide Injection Personalized GLP-1/GIP care with tirzepatide injection when clinically appropriate. $269 / mo* Month-to-month: $339 every 4 weeks 12 weeks upfront $927 · $309/mo 24 weeks upfront $1,734 · $289/mo 52 weeks upfront $3,497 · $269/mo” | Per month$309 | Charged today$927 |
| 24 weeks paid upfront “Tirzepatide Injection Personalized GLP-1/GIP care with tirzepatide injection when clinically appropriate. $269 / mo* Month-to-month: $339 every 4 weeks 12 weeks upfront $927 · $309/mo 24 weeks upfront $1,734 · $289/mo 52 weeks upfront $3,497 · $269/mo” | Per month$289 | Charged today$1,734 |
| 52 weeks paid upfront “Tirzepatide Injection Personalized GLP-1/GIP care with tirzepatide injection when clinically appropriate. $269 / mo* Month-to-month: $339 every 4 weeks 12 weeks upfront $927 · $309/mo 24 weeks upfront $1,734 · $289/mo 52 weeks upfront $3,497 · $269/mo” | Per month$269 | Charged today$3,497 |
We earn nothing from this link. Prime Doctor RX has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 13, 2026 — Entry added to the register
Sourcing and terms
| Pharmacy | Not disclosed |
|---|---|
| States | Not disclosed |
| Prescriber | Asynchronous review |
| Cancellation | “You may request cancellation of a month-to-month plan at any time. Cancellation stops future renewals; it does not automatically reverse a charge for a service period that has already begun. To help prevent the next scheduled renewal from processing, submit your cancellation request at least 72 hours before your next billing date.” |
| Membership | Not disclosed |
| Consult fee | None. “No hidden fees. Fees are shown before enrollment. Refunds can be requested at any time except for a month in which medication has already been ordered.” |
Recorded from primedoctorrx.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 13, 2026 — Prime Doctor RX quotes its own upfront totals beside each prepaid tier, so nothing here is multiplied out. Its month-to-month tier is billed every four weeks, not monthly: the plan cards read “$249 every 4 weeks” and the billing policy says charges run “on a recurring cycle, commonly every 28 days”. Thirteen such charges fall in a year rather than twelve, so the month-to-month figure recorded here is the company's own per-cycle price and not an annualized twelfth. The 52-week totals likewise exceed twelve times the advertised effective monthly rate, because that rate is stated over thirteen four-week cycles.
- 2. September 13, 2026 — Luvo Health (luvohealth.com) publishes an identical charge for every tier and every product on this list: $249, $657, $1,194 and $2,327 for injectable semaglutide, $339, $927, $1,734 and $3,497 for tirzepatide, $279, $777, $1,434 and $2,717 for the oral tablet. Two companies with different names, different sites and separate affiliate programs are selling one price book.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.